On Friday, Serina Therapeutics Inc (AMEX: SER) opened higher 3.70% from the last session, before settling in for the closing price of $5.13. Price fluctuations for SER have ranged from $3.81 to $10.28 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 33.30% annually for the last half of the decade. Company’s average yearly earnings per share was noted -33.11% at the time writing. With a float of $3.36 million, this company’s outstanding shares have now reached $10.14 million.
Serina Therapeutics Inc (SER) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Serina Therapeutics Inc is 67.22%, while institutional ownership is 4.06%. The most recent insider transaction that took place on Aug 26 ’25, was worth 319,880. In this transaction Chief Scientific Officer of this company sold 45,632 shares at a rate of $7.01, taking the stock ownership to the 0 shares. Before that another transaction happened on Aug 25 ’25, when Company’s Chief Scientific Officer sold 2,042 for $5.65, making the entire transaction worth $11,537. This insider now owns 0 shares in total.
Serina Therapeutics Inc (SER) Latest Financial update
Serina Therapeutics Inc (AMEX: SER) Trading Performance Indicators
Check out the current performance indicators for Serina Therapeutics Inc (SER). In the past quarter, the stock posted a quick ratio of 2.24. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 419.46.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.94, a number that is poised to hit -0.47 in the next quarter and is forecasted to reach -1.79 in one year’s time.
Technical Analysis of Serina Therapeutics Inc (SER)
Let’s dig in a bit further. During the last 5-days, its volume was 1.23 million. That was better than the volume of 53130.0 it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 13.60%.
During the past 100 days, Serina Therapeutics Inc’s (SER) raw stochastic average was set at 21.69%, which indicates a significant increase from 19.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.57 in the past 14 days, which was higher than the 0.43 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.51, while its 200-day Moving Average is $5.25. However, in the short run, Serina Therapeutics Inc’s stock first resistance to watch stands at $5.53. Second resistance stands at $5.75. The third major resistance level sits at $6.00. If the price goes on to break the first support level at $5.06, it is likely to go to the next support level at $4.81. The third support level lies at $4.59 if the price breaches the second support level.
Serina Therapeutics Inc (AMEX: SER) Key Stats
There are currently 10,251K shares outstanding in the company with a market cap of 54.53 million. Presently, the company’s annual sales total 60 K according to its annual income of -11,140 K. Last quarter, the company’s sales amounted to 130 K and its income totaled -6,450 K.
